Cite
HARVARD Citation
Grivas, P. et al. (2014). Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma. Cancer. 120 (5), pp. 692-701. [Online].